Facinicline hydrochloride

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameFacinicline hydrochloride
Drug Alias Namefaciniclinum盐酸法欣克兰盐酸法西克兰faciniclinafacinicline +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor protein alpha-7 subunit agonistsSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptorNeuronal acetylcholine receptor protein alpha-7 subunit
Therapy Area/IndicationsSchizophreniaCognition DisordersAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSlovakia +[13] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMemory Pharmaceuticals CorpF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsSchizophreniaCognition DisordersAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A